Abstract
This report analyzes the Global Market for Small Molecule Kinase Inhibitors in
Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva,
Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb, and Others. Annual forecasts
are provided for the period 2006 through 2015. The report profiles 83
companies including many key and niche players worldwide such as Amgen, Inc.,
Asahi Kasei Pharma Corporation, AstraZeneca plc., Bayer Schering Pharma AG,
Bristol-Myers Squibb Company,.Celgene Corporation, Exelixis, Inc., F.
Hoffmann-La Roche, Ltd., Chugai Pharmaceutical Co, Ltd., Genentech, Inc.,
GlaxoSmithKline plc., KAI Pharmaceuticals, Inc., Merck & Co., Inc., Mitsubishi
Tanabe Pharma Corporation, Novartis International AG, Onyx Pharmaceuticals,
Inc., OSI Pharmaceuticals, Inc., Pfizer, Inc., Takeda Pharmaceutical Company
Limited, Millennium Pharmaceuticals Inc, S*Bio Pte Ltd., Sanofi-Aventis,
Vertex Pharmaceuticals Incorporated, and Wyeth. Market data and analytics are
derived from primary and secondary research. Company profiles are mostly
extracted from URL research and reported select online sources.
| 
View Cart
